Yan, Xiaohong

Roswell Park Comprehensive Cancer Center · Memorial Sloan Kettering Cancer Center · University of California, Irvine · University of California San Diego · NYU Langone Health · Massachusetts General Hospital · Mirati Therapeutics (United States) · Dana-Farber Cancer Institute · Weill Cornell Medicine · NYU Langone’s Laura and Isaac Perlmutter Cancer Center · University of Colorado Anschutz · New York University

3 papers on CoChat

Most cited papers

Verified
Adagrasib in Non–Small-Cell Lung Cancer Harboring a KRAS G12C Mutation
Jänne, P. A., Riely, G. J., Gadgeel, S. M., Heist, R. S., Ou, S.-H. I., Pacheco, J. M., Johnson, M. L., Sabari, J. K., Leventakos, K., Yau, E., et al. (2022) · New England Journal of Medicine
Lung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment
Cited by 1,061
Verified
First-in-Human Phase I/IB Dose-Finding Study of Adagrasib (MRTX849) in Patients With Advanced KRAS G12C Solid Tumors (KRYSTAL-1)
Ou, S.-H. I., Jänne, P. A., Leal, T. A., Rybkin, I. I., Sabari, J. K., Barve, M. A., Bazhenova, L., Johnson, M. L., Velastegui, K. L., Cilliers, C., et al. (2022) · Journal of Clinical Oncology
Lung Cancer Treatments and MutationsProtein Kinase Regulation and GTPase Signaling
Cited by 322
Verified
KRYSTAL-2: A phase I/II trial of adagrasib (MRTX849) in combination with TNO155 in patients with advanced solid tumors with KRAS G12C mutation.
Sabari, J. K., Park, H., Tolcher, A. W., Ou, S.-H. I., Garon, E. B., George, B., Janne, P. A., Moody, S. E., Tan, E. Y., Sen, S. K., et al. (2021) · Journal of Clinical Oncology
Protein Tyrosine PhosphatasesProtein Kinase Regulation and GTPase Signaling
Cited by 50

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.